Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Justice Department Sues Walgreens Over Alleged Unlawful Opioid Prescriptions

Jan 22, 2025 | False Claims Act

A nationwide civil complaint has been filed against Walgreens Boots Alliance, Walgreen Co. and various subsidiaries (“Walgreens”) in the U.S. District Court for the Northern District of Illinois. The 300-page complaint allege, inter alia, that the pharmacy giant...

District Court Adopts ‘But-For’ Causation Standard for FCA Claims Based on AKS Violations

Jan 17, 2025 | False Claims Act

Judge Saris of the U.S. District Court for the District of Massachusetts granted summary judgment in favor of the defendants in a qui tam action, ruling that the “but-for” causation standard should be applied when violations of the Anti-Kickback Statute (AKS) form the...

False Claims Act Settlements and Judgments Exceed $2.9B in Fiscal Year 2024

Jan 16, 2025 | False Claims Act

On January 15, 2025, the DOJ announced that its False Claims Act (FCA) recovery for fiscal year 2024 (which ended on September 30, 2024) exceeded $2.9 billion. This figure is slightly higher than the total recovery from the prior fiscal year ($2.7B) and the year...

Annual Defense Appropriations Legislation Brings Major Changes to Administrative False Claim Act

Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025.  This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961.  Generally speaking, the NDAA governs Department of...

Biopharmaceutical Company Agrees to Pay Over $4M to Resolve Allegations of NIH Grant Fraud

Jan 8, 2025 | False Claims Act, Fraud Investigations

Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...

Booz Allen Will Pay $15.875 Million to Settle FCA Allegations

Jan 6, 2025 | Code Enforcement, False Claims Act, ommercial payor audits

The DOJ has announced that Booz Allen Hamilton Holding Corporation (“Booz Allen”) will pay $15.875 million to resolve allegations that it violated the False Claims Act (“FCA”).  According to the DOJ, between approximately 2013 and 2018, Booz Allen Hamilton Engineering...
« Older Entries
Next Entries »

Recent Posts

  • Kendrick 1, Drake 0: Federal Judge Dismisses Drake’s Claims Against Distributor Over Kendrick Lamar Diss Track
  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group